External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

SMFM Pregnancy Meeting 2025

-
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features

Jan 30 / Roche
Reference range for Elecsys sFlt-1/PlGF ratio in a diverse U.S population
The sFlt-1/PlGF ratio test is used for the clinical prediction of preeclampsia in many countries worldwide but has not been widely adopted in the US. This study aimed to determine the reference range for the Roche Elecsys sFlt-1/PlGF ratio (electrochemiluminescent immunoassays) in a racially and ethnically diverse healthy US population of pregnant women at 23+0 - 34+6 gestational weeks.
05:30 PM
Duration 2hrs Denver, Colorado
Reference range for Elecsys sFlt-1/PlGF ratio in a diverse U.S population
Antonio Saad

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar